covidien

Covidien has obtained US Food and Drug Administration (FDA) 510(k) clearance for its Puritan Bennett 980 ventilator, the new acute care ventilator that delivers advanced breath technology for patients comfort and ease-of-use for clinicians.

By using new advanced synchrony tools, the Puritan Bennett 980 ventilator helps clinicians set the ventilator to adapt to their patients’ unique needs and provide the appropriate level of support throughout the breath.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The Puritan Bennett 980 ventilator system is designed for patients ranging from neonatal to adult.

It offers a range of software capabilities, including proportional assist ventilation plus (PAV) and leak sync software.

PAV software for the Puritan Bennett 980 ventilator is a breath type that better manages work of breathing in spontaneously breathing patients and promotes natural breathing compared with conventional mechanical ventilation.

According to the company, this software has been shown to help reduce asynchrony, which studies have shown may reduce days on mechanical ventilation.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

With its range of software capabilities, the new ventilator system helps clinicians to get patients off mechanical ventilation as soon as possible.

Covidien respiratory solutions vice-president and general manager James E Willett said: "The Puritan Bennett 980 ventilator provides clinicians with a simple, safe and smart way to care for patients."

The company expects to launch the ventilator system in Japan and Canada, where it was earlier approved for commercial distribution, along with the US in the coming months.

According to GlobalData estimates, the US ventilators market was valued at $163.9m in 2012 and is expected to grow at a CAGR of 3.4% to reach $206.4m by 2019.

Image: Puritan Bennett 980 ventilator gets FDA clearance. Photo: courtesy of Covidien/Business Wire.

Medical Device Network Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Medical Device Network Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving medical devices advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now